Synedica Retatrutide 40mg Pharmaceutical Injectable Prefilled Pen Specification
- Packaging Type
- Prefilled Pen
- Ingredients
- This is an experimental triple-hormone agonist (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly, primarily investigated in clinical trials for weight loss, type 2 diabetes, and non-alcoholic fatty liver disease
- Suitable For
- Adults, Aged Person
About Synedica Retatrutide 40mg Pharmaceutical Injectable Prefilled Pen
is an experimental triple-hormone agonist (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly, primarily investigated in clinical trials for weight loss, type 2 diabetes, and non-alcoholic fatty liver disease